| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 4921 | 1,350,061 | 1,904,077 |
| INVESTMENT - MS 8754 | 179,789 | 189,571 |
| INVESTMENT - MS 6772 | 129,487 | 129,487 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| INVESTMENT IN FOREST DEVICES INC | AT COST | 12,000 | 12,000 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA LLC | 13,086 | 13,086 | 13,086 |
| INVESTMENT IN 4J THERAPEUTICS INC | 380,000 | 505,000 | 505,000 |
| OAKTREE STRATEGIC CREDIT FUND | 450,000 | 450,000 | 438,721 |
| HTX GYB1 0124 INVESTMENT LLC (GPG- GLYCOS BIO) | 97,755 | 95,954 | 95,954 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK CHARGES | 44 | 44 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MORGAN STANLEY #4921 | 29 | 29 | 29 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 189 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 18,875 | 18,875 | 0 | |
| K-1 PORTFOLIO DEDUCTIONS | 1,801 | 1,801 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 219 | 219 | 0 | |
| FEDERAL TAXES | 4,818 | 0 | 0 |